Volume 3.21 | Jun 2

Cord Blood News 3.21, June 2, 2011
     In this issue: Science News | Current Publications | Industry News | Policy News | Events
Cell Therapy News on Facebook  Cord Blood News on Twitter

Neurexophilin 1 Suppresses the Proliferation of Hematopoietic Progenitor Cells
Researchers evaluated effects of neurexophilins on human cord blood and murine bone marrow hematopoietic progenitor and stem cells. [Blood]


CURRENT PUBLICATIONS (Ranked by Impact Factor of the Journal)

Maternal and Gestational Factors and Micronuclei Frequencies in Umbilical Blood: the NewGeneris Rhea Cohort in Crete
Researchers investigated the formation of micronuclei in full term and preterm newborns and their mothers from the Rhea cohort (Crete) applying for the first time in cord blood a validated semi-automated analysis system, in both mono- and binucleated T-lymphocytes. [Environ Health Perspect]

T Cells Raised Against Allogeneic HLA-A2/CD20 Kill Primary Follicular Lymphoma and Acute Lymphoblastic Leukemia Cells
Researchers recently demonstrated that highly peptide- and HLA-specific T cells can be readily generated against allogeneic HLA-A*02:01 in complex with a peptide from the B cell-restricted protein CD20. In the present study, they show that such CD20-specific T cells can easily be induced from naïve precursors in cord blood, demonstrating that they do not represent cross-reactive memory cells. [Int J Cancer]

Mitochondrial Function and Energy Metabolism in Umbilical Cord Blood – and Bone Marrow-Derived Mesenchymal Stem Cells
The present work focuses on the mitochondrial function of human mesenchymal stem cells from umbilical cord blood, bone marrow cells from donors under 18 years old (BMMSC<18) and over 50 years old (BMMSC>50). [Stem Cells Dev]

Characterization of Human Late Outgrowth Endothelial Progenitor-Derived Cells under Various Flow Conditions
Endothelial progenitor-derived cells were isolated from human cord blood, cultured on compliant tubes and exposed in an in vitro flow system mimicking hemodynamic environments normally found in medium and large arteries. [J Vasc Res]

Distribution of Dystrophin- and Utrophin-associated Protein Complexes (DAPC/UAPC) in Human Hematopoietic Stem/Progenitor Cells
In the present study, researchers characterized pattern expression by immunoblot technique and, by confocal microscopy analysis, the cellular distribution of dystrophin and utrophin gene products, and the dystrophin-associated proteins (α-, β-dystroglycan, α-syntrophin, α-dystrobrevin) in relation to actin filaments in freshly isolated CD34+ cells from umbilical cord blood. [Eur J Haematol]

Isolation of Mesenchymal Stem Cells using the Total Length of Umbilical Cord for Transplantation Purposes
Here, researchers report a detailed enzymatic method where a large number of cells can be efficiently isolated from the cord matrix and cryopreserved on the same day of arrival at the laboratory. [Transfus Med]

Maternal Understanding of Commercial Cord Blood Storage for their Offspring – A Survey among Pregnant Women in Hong Kong
The survey explored knowledge about the use of self-stored umbilical cord blood stem cells and attitude towards cord blood banking. [Acta Obstet Gynecol Scand]

Umbilical Cord Blood Banking: An Update
This review summarizes the status of umbilical cord blood banking, its history and current and potential use in the treatment of human disease. [J Assist Reprod Genet]



Cord Blood America Secures Acquisition Financing
Cord Blood America, Inc. announced that the Company has filed a Form S-1 with the U.S. Securities and Exchange Commission in connection with its Securities Purchase Agreement with Tangiers Investors, L.P., with whom Cord Blood America has an existing Securities Purchase Agreement. [Cord Blood America, Inc. Press Release]

Insception.com Launches Website to Encourage Cord Blood Banking
Insception Cord Blood Program has created a new state-of-the-art website to inform the general public about umbilical cord blood with quick and easy access to important facts and data about cord blood technology. [Marketwire]

Cryo-Save and Lazaron Biotechnologies Establish Stem Cell Bank Joint Venture in South Africa
Cryo-Save Group N.V., the leading international family stem cell bank, and John Daniel Holdings Ltd., a venture capital company and the controlling shareholder of Lazaron Biotechnologies (SA) Ltd, Africa’s first private cord blood stem cell bank, announced that the companies signed a memorandum of understanding to establish a new stem cell bank joint venture in South Africa. [Lazaron Biotechnologies Limited Press Release]

National Institutes of Health (United States)

Food and Drug Administration (United States)

Center for Biologics Evaluation and Research (United States)

European Medicines Agency (European Union)

Medicines and Healthcare Products Regulatory Agency (United Kingdom)

Therapeutic Goods Administration (Australia)
NEW Cold Spring Harbor – Cell Death
October 11-15, 2011
Cold Spring Harbor, United States

Visit our events page to see a complete list of events in the cord blood community.

Quality Assurance Manager – Program in Children’s Regenerative Medicine (The University of Texas Medical School at Houston)

Supervisor Cell Therapy Laboratory – Cord Blood Bank (The University of Texas MD Anderson Cancer Center)

Supervisor Cell Therapy Lab (The University of Texas MD Anderson Cancer Center)

Chemist (STEMCELL Technologies) 

Lab Technologist – Cell Separation (STEMCELL Technologies)

Research and Development Senior Technologist (STEMCELL Technologies)

Recruit Top Talent
Reach more than 11,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.

Jobs are categorized regionally: United States, Canada, Europe, Asia Pacific

Visit here to post your career opportunities.

Have we missed an important article or publication in Cord Blood News? Click here to submit!

Comments or Suggestions? Email [email protected] with your feedback.

Learn more about Cord Blood News: Archives | Events | Contact Us